loadpatents
name:-0.018671989440918
name:-0.012476205825806
name:-0.011133909225464
Bell; Noah Patent Filings

Bell; Noah

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bell; Noah.The latest application filed is for "substituted 4-phenyl pyridine compounds as non-systemic tgr5 agonists".

Company Profile
9.19.25
  • Bell; Noah - Fremont CA
  • Bell; Noah - Berkeley CA
  • Bell; Noah - Los Angeles CA
  • BELL; NOAH - Jerusalem IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted 4-phenyl Pyridine Compounds As Non-systemic Tgr5 Agonists
App 20220306672 - Lewis; Jason G. ;   et al.
2022-09-29
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
Grant 11,318,129 - Charmot , et al. May 3, 2
2022-05-03
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
Grant 10,968,246 - Lewis , et al. April 6, 2
2021-04-06
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt
App 20200268741 - Charmot; Dominique ;   et al.
2020-08-27
Substituted 4-phenyl Pyridine Compounds As Non-systemic Tgr5 Agonists
App 20200062795 - Lewis; Jason G. ;   et al.
2020-02-27
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
Grant 10,543,207 - Charmot , et al. Ja
2020-01-28
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt
App 20190374533 - CHARMOT; Dominique ;   et al.
2019-12-12
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
Grant 10,392,413 - Lewis , et al. A
2019-08-27
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
Grant 10,385,024 - Bell , et al. A
2019-08-20
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
Grant 10,376,481 - Bell , et al. A
2019-08-13
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders
App 20190062279 - BELL; Noah ;   et al.
2019-02-28
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders
App 20170368004 - BELL; Noah ;   et al.
2017-12-28
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders
App 20170340623 - CHARMOT; Dominique ;   et al.
2017-11-30
Substituted 4-phenyl Pyridine Compounds As Non-systemic Tgr5 Agonists
App 20170174718 - LEWIS; Jason Gustaf ;   et al.
2017-06-22
System And Method For Protecting A User Of A Mobile Electronic Device From Radiation
App 20170047652 - Finkel; Vladimir ;   et al.
2017-02-16
Compounds And Methods For Inhibiting Phosphate Transport
App 20170037010 - Lewis; Jason G. ;   et al.
2017-02-09
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorder
Grant 9,408,840 - Bell , et al. August 9, 2
2016-08-09
Compounds and methods for inhibiting phosphate transport
Grant 9,301,951 - Lewis , et al. April 5, 2
2016-04-05
Compounds and methods for inhibiting phosphate transport
Grant 9,289,429 - Lewis , et al. March 22, 2
2016-03-22
Compounds and methods for inhibiting phosphate transport
Grant 9,289,430 - Lewis , et al. March 22, 2
2016-03-22
Compounds and methods for inhibiting phosphate transport
Grant 9,278,102 - Lewis , et al. March 8, 2
2016-03-08
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders
App 20150336892 - LEADBETTER; Michael ;   et al.
2015-11-26
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders
App 20150299131 - BELL; Noah ;   et al.
2015-10-22
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorder
App 20150190389 - BELL; Noah ;   et al.
2015-07-09
Compounds And Methods For Inhibiting Phosphate Transport
App 20150164905 - Lewis; Jason G. ;   et al.
2015-06-18
Compounds And Methods For Inhibiting Phosphate Transport
App 20150164876 - Lewis; Jason G. ;   et al.
2015-06-18
Compounds And Methods For Inhibiting Phosphate Transport
App 20150164904 - Lewis; Jason G. ;   et al.
2015-06-18
Compounds And Methods For Inhibiting Phosphate Transport
App 20150157637 - Lewis; Jason G. ;   et al.
2015-06-11
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
Grant 9,006,281 - Bell , et al. April 14, 2
2015-04-14
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
Grant 8,969,377 - Bell , et al. March 3, 2
2015-03-03
Compounds and methods for inhibiting phosphate transport
Grant 8,916,569 - Lewis , et al. December 23, 2
2014-12-23
Compounds and methods for inhibiting phosphate transport
Grant 8,815,910 - Lewis , et al. August 26, 2
2014-08-26
Compounds and methods for inhibiting phosphate transport
Grant 8,815,908 - Lewis , et al. August 26, 2
2014-08-26
Compounds and methods for inhibiting phosphate transport
Grant 8,809,339 - Lewis , et al. August 19, 2
2014-08-19
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders
App 20140107074 - BELL; Noah ;   et al.
2014-04-17
Compounds And Methods For Inhibiting Phosphate Transport
App 20140023611 - Lewis; Jason G. ;   et al.
2014-01-23
Compounds And Methods For Inhibiting Phosphate Transport
App 20130336920 - Lewis; Jason G. ;   et al.
2013-12-19
Compounds And Methods For Inhibiting Phosphate Transport
App 20130336918 - Lewis; Jason G. ;   et al.
2013-12-19
Compounds And Methods For Inhibiting Phosphate Transport
App 20130336919 - Lewis; Jason G. ;   et al.
2013-12-19
Compounds And Methods For Inhibiting Phosphate Transport
App 20130336921 - Lewis; Jason G. ;   et al.
2013-12-19
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders
App 20130274285 - BELL; Noah ;   et al.
2013-10-17
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
Grant 8,541,448 - Charmot , et al. September 24, 2
2013-09-24
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders
App 20120263670 - Charmot; Dominique ;   et al.
2012-10-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed